Alliqua Biomedical (ALQA) Stock Price, News & Analysis

Company Overview

Alliqua BioMedical, Inc. develops, manufactures, and markets high water content, electron beam cross-linked, and aqueous polymer hydrogels or gels used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It also provides contract manufacturing services to the OEM market. The company is headquartered in Langhorne, Pennsylvania.

Key Stats

• Today's Range: N/A
• 50-Day Range: $2.20 to $3.23
• 52-Week Range: N/A
• Volume: 371,516 shs
• Average Volume: 114,400 shs
• Market Capitalization: $13.46 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ALQA Stock Analysis - Frequently Asked Questions

How were Alliqua Biomedical's earnings last quarter?

Alliqua Biomedical Inc (NASDAQ:ALQA) released its earnings results on Tuesday, August, 9th. The company reported $0.50 EPS for the quarter, topping analysts' consensus estimates of ($2.70) by $3.20. The firm earned $5.50 million during the quarter, compared to analyst estimates of $5.38 million. Alliqua Biomedical had a negative net margin of 230.50% and a negative trailing twelve-month return on equity of 71.73%.

When did Alliqua Biomedical's stock split?

Alliqua Biomedical shares reverse split on the morning of Friday, October 6th 2017. The 1-10 reverse split was announced on Thursday, October 5th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 5th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Alliqua Biomedical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Alliqua Biomedical investors own include Palatin Technologies (PTN), ContraVir Pharmaceuticals (CTRV), Argos Therapeutics (ARGSQ), Consolidated Water (CWCO), Bristol-Myers Squibb (BMY), Biopharmx (BPMX) and Ritter Pharmaceuticals (RTTR).

Company Calendar

• Last Earnings: 8/09/2016
• Today: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & Medical Instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:ALQA
• CIK: 1054274
• Web: www.alliqua.com
• Phone: 215-702-8550
• Fax: N/A
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-8,420,000.00
• Net Margins: -230.50%
• Pretax Margin: N/A
• Return on Equity: -71.73%
• Return on Assets: -55.23%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 8.28
• Quick Ratio: 8.17

Sales & Book Value

• Annual Sales: $2.22 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.65 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 5,010,000
• Free Float: N/A
• Market Cap: $13.46 million
• Optionable: Not Optionable
• Beta: 2.03